1h Free Analyst Time
The kidney transplantation therapeutics market is forecasted to grow by USD 643.15 mn during 2023-2028, accelerating at a CAGR of 4.49% during the forecast period. The report on the kidney transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of CKD and renal impairments, availability of drugs in multiple dosage forms, and high dependency on immunosuppressants for kidney transplantation.
The kidney transplantation therapeutics market is segmented as below:
By Product
- Selective cytokine inhibitors
- Immunosuppressive antimetabolites
- Other drug
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the kidney transplantation therapeutics market covers the following areas:
- Kidney transplantation therapeutics market sizing
- Kidney transplantation therapeutics market forecast
- Kidney transplantation therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global kidney transplantation therapeutics market: AbbVie Inc., Asahi Kasei Corp., Astellas Pharma Inc., B.Braun SE, Bristol Myers Squibb Co., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, GlaxoSmithKline Plc, Hansa Biopharma AB, Novartis AG, Organ Recovery Systems Inc., Pfizer Inc., Sanofi SA, Strides Pharma Science Ltd., TFF Pharmaceuticals Inc., TolerogenixX GmbH, TransMedics Inc., and Transonic Systems Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is novel techniques for kidney transplantation.'
According to the report, one of the major drivers for this market is the rising prevalence of CKD and renal impairments.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Asahi Kasei Corp.
- Astellas Pharma Inc.
- B.Braun SE
- Bristol Myers Squibb Co.
- Dr Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- Fresenius Medical Care AG and Co. KGaA
- GlaxoSmithKline Plc
- Hansa Biopharma AB
- Novartis AG
- Organ Recovery Systems Inc.
- Pfizer Inc.
- Sanofi SA
- Strides Pharma Science Ltd.
- TFF Pharmaceuticals Inc.
- TolerogenixX GmbH
- TransMedics Inc.
- Transonic Systems Inc.
